BBB opening can increase the local concentration of therapeutic agents in the brain without damaging normal tissue, and via FUS-BBB opening to enhance CNS penetration of AD-treated therapeutic agents is an attractive approach
These medications effectively suppress appetite, leading to significant fat loss
Moderate deficiency causes peripheral neuropathy, characterized by numbness, tingling, and weakness in the hands and feet
GLP-1 side effects like nausea, reduced appetite, or digestive changes are caused by how the medication works throughout your body after absorption, not by where you inject it
10.1016/j.jamda.2014.09.010 97 FilardiM.BaroneR.BramatoG.NigroS.TafuriB.FrisulloM
That said, safety is generally a function of health and dosage, so it is important that you speak with a registered healthcare provider before beginning the therapy to rule out any contraindications and get ongoing evaluation of your progress